{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:38:50Z","timestamp":1777430330396,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s10822-009-9299-7","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T22:18:29Z","timestamp":1252448309000},"page":"807-828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the \u03b22-adrenergic receptor and the human adenosine A2A receptor"],"prefix":"10.1007","volume":"23","author":[{"given":"Farag F.","family":"Sherbiny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke C.","family":"Schiedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Maa\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"9299_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom MC, Schi\u00f6th HB (2008) Structural diversity of G protein-coupled receptor and significance for drug discovery. Nat Rev Drug Discov 7:339\u2013357","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"9299_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5(12):993\u2013996","journal-title":"Nat Rev Drug Discov"},{"key":"9299_CR3","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.33549\/physiolres.930000.53.S141","volume":"53","author":"P Svoboda","year":"2004","unstructured":"Svoboda P, Teisinger J, Novotny J, Bourova L, Drmota T, Hejnova L, Moravcova Z, Lisy V, Rudajev V, St\u00f6hr J, Vokurkova A, Svandova I, Durchankova D (2004) Biochemistry of transmembrane signalling mediated by trimeric G proteins. Physiol Res 53:S141\u2013S152","journal-title":"Physiol Res"},{"key":"9299_CR4","unstructured":"B\u00f6hm HJ, Klebe G, Kubinyi H (1996) Wirkstoffdesign Der Weg zum Arzneimittel, 1st edn. Spektrum Akademischer Verlag, Heidelberg. ISBN 13:978-3827413536"},{"key":"9299_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0165-6147(96)01038-3","volume":"18","author":"BB Fredholm","year":"1997","unstructured":"Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M (1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18:79\u201382","journal-title":"Trends Pharmacol Sci"},{"key":"9299_CR6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Klotz K-N, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"9299_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1381612802666221004174507","volume":"2","author":"CE M\u00fcller","year":"1996","unstructured":"M\u00fcller CE, Stein B (1996) Adenosine receptor antagonists: structures and potential therapeutic applications. Curr Pharm Design 2:501\u2013530","journal-title":"Curr Pharm Design"},{"key":"9299_CR8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2174\/0929867003374101","volume":"7","author":"CE M\u00fcller","year":"2000","unstructured":"M\u00fcller CE (2000) Adenosine receptor ligands: recent developments part I. Agonists. Curr Med Chem 7:1269\u20131288","journal-title":"Curr Med Chem"},{"key":"9299_CR9","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1371\/journal.pmed.0050137","volume":"5","author":"A Grenz","year":"2008","unstructured":"Grenz A, Osswald H, Eckle T, Yanq D, Zhang H, Tran ZV, Klingel K, Ravid K, Eltzschig HK (2008) The reno-vascular A2Badenosine receptor protects the kidney from ischemia. PLoS Med 5:e137","journal-title":"PLoS Med"},{"key":"9299_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/1568026033392264","volume":"3","author":"R Volpini","year":"2003","unstructured":"Volpini R, Costanzi S, Vittori S, Cristalli G, Klotz KN (2003) Medicinal chemistry and pharmacology of A2B adenosine receptors. Curr Top Med Chem 3:427\u2013443","journal-title":"Curr Top Med Chem"},{"key":"9299_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bjp.0706272","volume":"145","author":"ST Holgate","year":"2005","unstructured":"Holgate ST (2005) the Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptors as a novel therapeutic target in asthma. Br J Pharmacol 145:1009\u20131015","journal-title":"Br J Pharmacol"},{"key":"9299_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.289.5480.739","volume":"289","author":"K Palczewski","year":"2000","unstructured":"Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739\u2013745","journal-title":"Science"},{"key":"9299_CR13","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1021\/jm049418o","volume":"48","author":"AA Ivanov","year":"2005","unstructured":"Ivanov AA, Baskin II, Palyulin VA, Piccagli L, Baraldi PG, Zefirov NS (2005) Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists. J Med Chem 48:6813\u20136820","journal-title":"J Med Chem"},{"key":"9299_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jmb.2004.07.044","volume":"342","author":"T Okada","year":"2004","unstructured":"Okada T, Sugihara M, Bondar AN, Elstner M, Entel P, Buss V (2004) The retinal conformation and its environment in rhodopsin in light of a new 2.2 \u00c5 crystal structure. J Mol Biol 342:571\u2013583","journal-title":"J Mol Biol"},{"key":"9299_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High resolution crystal structure of an engineered human \u00df2-adrenergic G protein-coupled receptor. Science 318:1258\u20131265","journal-title":"Science"},{"issue":"5905","key":"9299_CR16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1164772","volume":"322","author":"V-P Jaakola","year":"2008","unstructured":"Jaakola V-P, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, IJzerman AP, Stevens RC (2008) The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322(5905):1211\u20131217","journal-title":"Science"},{"key":"9299_CR17","first-page":"6","volume-title":"Enzyme structure and mechanism","author":"A Fersht","year":"1985","unstructured":"Fersht A (1985) Enzyme structure and mechanism, 2nd edn. Freeman, New York, p 6","edition":"2"},{"key":"9299_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1529\/biophysj.106.082313","volume":"91","author":"LR Forrest","year":"2006","unstructured":"Forrest LR, Tang CL, Honig B (2006) on the accuracy of homology modeling and sequence alignment methods applied to membrane proteins. Biophys J 91:508\u2013517","journal-title":"Biophys J"},{"key":"9299_CR19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/ci8000265","volume":"48","author":"S Radestock","year":"2008","unstructured":"Radestock S, Weil T, Renner S (2008) Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring. J Chem Inf Model 48:1104\u20131117","journal-title":"J Chem Inf Model"},{"key":"9299_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00894-007-0207-6","volume":"13","author":"P Ferrara","year":"2007","unstructured":"Ferrara P, Jacoby E (2007) Evaluation of the utility of homology models in high throughput docking. J Mol Model 13:897\u2013905","journal-title":"J Mol Model"},{"key":"9299_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1021\/ci050238c","volume":"46","author":"V Kairys","year":"2006","unstructured":"Kairys V, Fernandes MX, Gilson MK (2006) Screening drug-like compounds by docking to homology models: a systematic study. J Chem Inf Model 46:365\u2013379","journal-title":"J Chem Inf Model"},{"key":"9299_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/nar\/28.1.45","volume":"28","author":"A Bairoch","year":"2000","unstructured":"Bairoch A, Apweiler R (2000) The SWISS-PROT protein sequence database and its supplement TrEMBL. Nucleic Acids Res 28:45\u201348","journal-title":"Nucleic Acids Res"},{"key":"9299_CR23","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","volume":"25","author":"JD Thompson","year":"1997","unstructured":"Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL: X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876\u20134882","journal-title":"Nucleic Acids Res"},{"key":"9299_CR24","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","volume":"63","author":"R Fredriksson","year":"2003","unstructured":"Fredriksson R, Lagerstr\u00f6m MC, Lundin L-G, Schi\u00f6th HB (2003) Mol Pharm 63:1256\u20131272","journal-title":"Mol Pharm"},{"key":"9299_CR25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/prot.20068","volume":"56","author":"T Imai","year":"2004","unstructured":"Imai T, Fujita N (2004) Statistical sequence analyses of G-protein-coupled receptors: structural and functional characteristics viewed with periodicities of entropy, hydrophobicity, and volume. Proteins Struct Funct Bioinf 56:650\u2013660","journal-title":"Proteins Struct Funct Bioinf"},{"key":"9299_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros JA, Weinstein HW (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure\u2013function relation of G protein-coupled receptors. Methods Neurosci 25:366\u2013428","journal-title":"Methods Neurosci"},{"key":"9299_CR27","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1110\/ps.03154503","volume":"212","author":"AA Canutescu","year":"2003","unstructured":"Canutescu AA, Shelenkov AA, Dunbrack RL Jr (2003) A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci 212:2001\u20132014","journal-title":"Protein Sci"},{"key":"9299_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","volume":"91","author":"DA Pearlman","year":"1995","unstructured":"Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, Debolt S, Ferguson D, Seibel G, Collman P (1995) AMBER, a package of computer-programs for applying molecular mechanics, normal-mode analysis, molecular-dynamics and free-energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 91:1\u201341","journal-title":"Comput Phys Commun"},{"key":"9299_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","volume":"261","author":"M Rarey","year":"1996","unstructured":"Rarey M, Kramer B, Lengauer T, Klebe G (1996) Prediction receptor\u2013ligand interaction by an incremental construction algorithm. J Mol Biol 261:470\u2013489","journal-title":"J Mol Biol"},{"key":"9299_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1023\/A:1007913026166","volume":"11","author":"M Rarey","year":"1997","unstructured":"Rarey M, Kramer B, Lengauer T (1997) Multiple automatic base selection: protein\u2013ligand docking based on incremental construction without manual intervention. J Comp Aided Mol Des 11:369\u2013384","journal-title":"J Comp Aided Mol Des"},{"key":"9299_CR31","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO;2-H","volume":"17","author":"J \u00c5quist","year":"1996","unstructured":"\u00c5quist J (1996) Calculation of absolute binding free energies for charged ligands and effects of long range electrostatic interactions. J Comp Chem 17:1587\u20131597","journal-title":"J Comp Chem"},{"key":"9299_CR32","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1021\/jm000241h","volume":"43","author":"B Kuhn","year":"2000","unstructured":"Kuhn B, Kollman PA (2000) Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. J Med Chem 43:3786\u20133791","journal-title":"J Med Chem"},{"key":"9299_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(SICI)1097-0134(19990101)34:1<69::AID-PROT6>3.0.CO;2-C","volume":"34","author":"J Wang","year":"1999","unstructured":"Wang J, Dixon R, Kollmann PA (1999) Ranking ligand binding affinities with avidin: a molecular dynamics-based interaction energy study. Proteins 34:69\u201381","journal-title":"Proteins"},{"key":"9299_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00894-005-0004-z","volume":"12","author":"B Schlegel","year":"2005","unstructured":"Schlegel B, Sippl W, H\u00f6ltje H\u2013D (2005) Molecular dynamics simulations of bovine rhodopsin: influence of protonation states and different membrane-mimicking environments. J Mol Model 12:49\u201364","journal-title":"J Mol Model"},{"key":"9299_CR35","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/emboj\/18.7.1723","volume":"18","author":"J Bockaert","year":"1999","unstructured":"Bockaert J, Pin JP (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723\u20131729","journal-title":"EMBO J"},{"key":"9299_CR36","first-page":"81","volume":"29","author":"P Pospisil","year":"2004","unstructured":"Pospisil P, Folkers G (2004) Making the best account of molecular docking in drug design. J Pharm Sci 29:81\u201392","journal-title":"J Pharm Sci"},{"key":"9299_CR37","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1126\/science.1150609","volume":"318","author":"DM Rosenbaum","year":"2007","unstructured":"Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK (2007) GPCR Engineering yields high-resolution structural insights into \u03b22-adrenergic receptor function. Science 318:1266\u20131273","journal-title":"Science"},{"issue":"8","key":"9299_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10822-007-9127-x","volume":"21","author":"B Schlegel","year":"2007","unstructured":"Schlegel B, Laggner C, Meier R, Langer T, Schnell D, Seifert R, Stark H, H\u00f6ltje HD, Sippl W (2007) Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening. J Comput Aided Mol Des 21(8):437\u2013454","journal-title":"J Comput Aided Mol Des"},{"key":"9299_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/138920306778559368","volume":"7","author":"WM Rockey","year":"2006","unstructured":"Rockey WM, Elcock AH (2006) Structure selection for protein kinase docking and virtual screening: homology models or crystal structures? Curr Protein Pept Sci 7:437\u2013457","journal-title":"Curr Protein Pept Sci"},{"key":"9299_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26:283\u2013291","journal-title":"J Appl Cryst"},{"key":"9299_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/prot.340120407","volume":"12","author":"AL Morris","year":"1992","unstructured":"Morris AL, MacArthur MW, Hutchinson EG, Thornton JM (1992) Stereochemical quality of protein structure coordinates. Proteins 12:345\u2013364","journal-title":"Proteins"},{"key":"9299_CR42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"MJ Sippl","year":"1993","unstructured":"Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins 17:355\u2013362. http:\/\/www.came.sbg.ac.at\/","journal-title":"Proteins"},{"key":"9299_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/PL00005326","volume":"359","author":"E Ongini","year":"1999","unstructured":"Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB (1999) Comparison of CGS15943, ZM241385 and Sch58261 as antagonists at human adenosine receptors. Naunyn\u2013Schmiedeberg\u2019s Arch Pharmacol 359:7\u201310","journal-title":"Naunyn\u2013Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9299_CR44","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1021\/jm9911480","volume":"43","author":"R Sauer","year":"2000","unstructured":"Sauer R, Maurinsh J, Reith U, F\u00fclle F, Klotz KN, M\u00fcller CE (2000) Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists. J Med Chem 43:440\u2013448","journal-title":"J Med Chem"},{"key":"9299_CR45","first-page":"668","volume":"2","author":"LJ Knutsen","year":"2001","unstructured":"Knutsen LJ, Weiss SM (2001) KW-6002 (Kyowa Hakko Kogyo). Curr Opin Invest Drugs 2:668\u2013673","journal-title":"Curr Opin Invest Drugs"},{"key":"9299_CR46","doi-asserted-by":"publisher","unstructured":"Hodgson RA, Bertorelli R, Varty GB, Lachowicz JE, Forlani A, Fredduzzi S, Cohen-Williams ME, Higgins GA, Impagnatiello F, Nicolussi E, Parra LE, Foster C, Zhai Y, Neustadt BR, Stamford AW, Parker EM, Reggiani A, Hunter JC (2009) Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH412348 in rodent models of movement disorders and depression. J Pharmacol Exp Ther. doi:10.1124\/jpet.108.149617","DOI":"10.1124\/jpet.108.149617"},{"key":"9299_CR47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/jm990421v","volume":"43","author":"YC Kim","year":"2000","unstructured":"Kim YC, Ji XD, Melman N, Linden J, Jacobson KA (2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A2B adenosine receptor. J Med Chem 43:1165\u20131172","journal-title":"J Med Chem"},{"key":"9299_CR48","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1021\/jm0309654","volume":"47","author":"PG Baraldi","year":"2004","unstructured":"Baraldi PG, Tabrizi MA, Preti D, Bovero A, Romagnoli R, Fruttarolo F, Zaid NA, Moorman AR, Varani K, Gessi S, Merighi S, Borea PA (2004) Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. J Med Chem 47:1434\u20131447","journal-title":"J Med Chem"},{"key":"9299_CR49","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1021\/jm060277v","volume":"49","author":"L Yan","year":"2006","unstructured":"Yan L, CG BertarelliD, Hayallah AM, Meyer H, Klotz K-N, M\u00fcller CE (2006) A new synthesis of sulfonamides by aminolysis of p-Nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists. J Med Chem 49:4384\u20134391","journal-title":"J Med Chem"},{"key":"9299_CR50","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.bcp.2004.06.011","volume":"68","author":"ZG Gao","year":"2004","unstructured":"Gao ZG, Mamedova LK, Chen P, Jacobson KA (2004) 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. Biochem Pharmacol 68:1985\u20131993","journal-title":"Biochem Pharmacol"},{"key":"9299_CR51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)21094-1","volume":"251","author":"MF Jarvis","year":"1989","unstructured":"Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M (1989) [3H] CGS21680, a selective A2 adenosine receptor agonist directly labels A2 receptor in rat brain. J Pharmacol Exp Ther 251:888\u2013893","journal-title":"J Pharmacol Exp Ther"},{"key":"9299_CR52","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.106.669697","volume":"115","author":"T Eckle","year":"2007","unstructured":"Eckle T, Krahn T, Grenz A, K\u00f6hler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK (2007) Cardioprotection by ecto-5\u2032-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581\u20131590","journal-title":"Circulation"},{"key":"9299_CR53","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1021\/jm0104318","volume":"45","author":"SA Kim","year":"2002","unstructured":"Kim SA, Marshall MA, Melman N, Kim HS, M\u00fcller CE, Linden J, Jacobson KA (2002) Structure\u2013activity relationships at human rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J Med Chem 45:2131\u20132138","journal-title":"J Med Chem"},{"key":"9299_CR54","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1021\/jm011049y","volume":"45","author":"AM Hayallah","year":"2002","unstructured":"Hayallah AM, Sandoval-Ramirez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, M\u00fcller CE (2002) 1, 8-Disubstituted xanthine derivatives: synthesis of potent A2B selective adenosine receptor antagonists. J Med Chem 45:1500\u20131510","journal-title":"J Med Chem"},{"key":"9299_CR55","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1021\/jm061333v","volume":"50","author":"B Vidal","year":"2007","unstructured":"Vidal B, Nueda A, Esteve C, Domench T, Benito S, Reinoso RF, Pont M, Calbet M, Lopez R, Cadavid MI, Loza MI, Cardenas A, Godessart N, Beleta J, Warrellow G, Ryder H (2007) Discovery and characterization of 4\u2032-(2-furyl)-N-pyridin-3-yl-4,5\u2032-bipyrimidin-2\u2032-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist. J Med Chem 50:2732\u20132736","journal-title":"J Med Chem"},{"key":"9299_CR56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bcp.2004.03.026","volume":"68","author":"M Stewart","year":"2004","unstructured":"Stewart M, Steinig AG, Ma C, Song JP, McKibben B, Castelhano AL, MacLennan SJ (2004) [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors. Biochem Pharmacol 68:305\u2013312","journal-title":"Biochem Pharmacol"},{"key":"9299_CR57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/15257779908041560","volume":"18","author":"S Vittori","year":"1999","unstructured":"Vittori S, Camaioni E, Costanzi S, Volpini R, Klotz KN, Cristalli G (1999) Synthesis and receptor affinity of polysubstituted adenosine. Nucleosid Nucleotid 18:739\u2013740","journal-title":"Nucleosid Nucleotid"},{"key":"9299_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/PL00005131","volume":"357","author":"KN Klotz","year":"1998","unstructured":"Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 357:1\u20139","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9299_CR59","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jmgm.2006.06.004","volume":"25","author":"AA Ivanov","year":"2007","unstructured":"Ivanov AA, Palyulin VA, Zefirov NS (2007) Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors. J Mol Graphics Model 25:740\u2013754","journal-title":"J Mol Graphics Model"},{"key":"9299_CR60","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1021\/jm061170a","volume":"50","author":"PG Baraldi","year":"2007","unstructured":"Baraldi PG, Preti D, Tabrizi MA, Fruttarolo F, Romagnoli R, Carrion MD, Cara LCL, Moorman AR, Varani K, Borea PA (2007) Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-\u03b2-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists. J Med Chem 50:374\u2013380","journal-title":"J Med Chem"},{"key":"9299_CR61","doi-asserted-by":"publisher","first-page":"07063","DOI":"10.1038\/nature07063","volume":"454","author":"JH Park","year":"2008","unstructured":"Park JH, Scheerer P, Hofmann KP, Choe H-W, Ernst OP (2008) Crystal structure of the ligand-free G protein-coupled receptor opsin. Nature 454:07063","journal-title":"Nature"},{"key":"9299_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0014-2999(96)00495-5","volume":"310","author":"AP IJzerman","year":"1996","unstructured":"IJzerman AP, Von Frijtag Drabbe K\u00fcnzel JK, Kim J, Jiang Q, Jacobson KA (1996) Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition. Eur J Pharmacol 310:269\u2013272","journal-title":"Eur J Pharmacol"},{"key":"9299_CR63","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0026-895X(24)12707-1","volume":"58","author":"MW Beukers","year":"2000","unstructured":"Beukers MW, den Dulk H, van Tilburg EW, Brouwer J, IJzerman AP (2000) Why are A2B receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of the human A2B receptor for 2-(1-hexynyl) adenosine. Mol Pharmacol 58:1349\u20131356","journal-title":"Mol Pharmacol"},{"key":"9299_CR64","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1021\/jm970084v","volume":"40","author":"Q Jiang","year":"1997","unstructured":"Jiang Q, Lee BX, Glashofer M, van Rhee AM, Jacobson KA (1997) Mutagenesis reveals structure\u2013activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors. J Med Chem 40:2588\u20132595","journal-title":"J Med Chem"},{"key":"9299_CR65","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0026-895X(25)09303-4","volume":"50","author":"Q Jiang","year":"1996","unstructured":"Jiang Q, van Rhee AM, Kim J, Yehle S, Wess J, Jacobson KA (1996) Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptor are required for ligand recognition. Mol Pharmacol 50:512\u2013521","journal-title":"Mol Pharmacol"},{"key":"9299_CR66","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1124\/mol.65.3.702","volume":"65","author":"MW Beukers","year":"2004","unstructured":"Beukers MW, van Oppenraaij J, van der Hoorn PP, Blad CC, den Dulk H, Brouwer J, IJzerman AP (2004) Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast, identification of constitutively active and gain of function mutations. Mol Pharmacol 65:702\u2013710","journal-title":"Mol Pharmacol"},{"key":"9299_CR67","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0026-895X(25)08783-8","volume":"49","author":"J Kim","year":"1996","unstructured":"Kim J, Jiang Q, Glashofer M, Yehle S, Wees J, Jacobson KA (1996) Glutamate residues in the second extracellular loop of the human A2A adenosine receptor are required for ligand recognition. Mol Pharmacol 49:683\u2013691","journal-title":"Mol Pharmacol"},{"key":"9299_CR68","doi-asserted-by":"publisher","first-page":"13987","DOI":"10.1074\/jbc.270.23.13987","volume":"270","author":"J Kim","year":"1995","unstructured":"Kim J, Wess J, van Rhee AM, Sch\u00f6neberg T, Jacobson KA (1995) Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2A adenosine receptor. J Biol Chem 270:13987\u201313997","journal-title":"J Biol Chem"},{"key":"9299_CR69","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0006-2952(00)00357-9","volume":"60","author":"Z-G Gao","year":"2000","unstructured":"Gao Z-G, Jiang Q, Jacobson KA, IJzerman AP (2000) Site-directed mutagenesis studies of human A2A adenosine receptors: involvement of Glu13 and His278 in ligand binding and sodium modulation. Biochem Pharmacol 60:661\u2013668","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-009-9299-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9299-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:13:06Z","timestamp":1744168386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-009-9299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["9299"],"URL":"https:\/\/doi.org\/10.1007\/s10822-009-9299-7","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]},"assertion":[{"value":"3 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}